Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations

High-risk relapsed/refractory adult Philadelphia-negative (Ph−) B-cell acute lymphoblastic leukemia (B-ALL) is a great challenge due to limited possibilities to achieve and maintain a complete response. This also applies to cases with extramedullary (EM) involvement that have poor outcomes and no ac...

Повний опис

Бібліографічні деталі

Автори:	Anna Ferrari, Delia Cangini, Andrea Ghelli Luserna di Rorà, Annalisa Condorelli, Marta Pugliese, Giovanni Schininà, Sebastiano Cosentino, Eugenio Fonzi, Chiara Domizio, Giorgia Simonetti, Salvatore Leotta, Giuseppe Milone, Giovanni Martinelli
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-05-01
Серія:	Frontiers in Cell and Developmental Biology
Предмети:	acute lymphoblastic leukemia venetoclax (BCL-2 inhibitor) Philadelphia-negative cells JAK/STAT extramedullary
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fcell.2023.1165308/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!